ALLMedicine™ Peptic Ulcer Disease Center

May 12th, 2022 - Helicobacter pylori infection is a well-established risk factor for peptic ulcer disease and gastric cancer. It's now a consensus of experts that H.pylori infection should be treated once it is recognized. Extended proton pump inhibitor (PPI)-base...

May 5th, 2022 - Helicobacter pylori Infection Treatment Regimens for eradication of Helicobacter pylori infection are typically chosen empirically, on the basis of regional bacterial resistance patterns, local recommendations, and drug availability. [1] Health ca...

May 5th, 2022 - Regimens for eradication of Helicobacter pylori infection are typically chosen empirically, on the basis of regional bacterial resistance patterns, local recommendations, and drug availability.[1] Health care providers should ask their patients ab...

Apr 13th, 2022 - Migraine is a common disease worldwide, and recent studies showed that the incidence of migraine was increased in patients with gastrointestinal (GI) diseases. In addition, preclinical evidence suggested a bidirectional relationship between the GI...

Apr 7th, 2022 - Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H...

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

Jan 11th, 2020 - Peptic ulcer disease is common with a lifetime prevalence in the general population of 5-10% and an incidence of 0.1-0.3% per year. Despite a sharp reduction in incidence and rates of hospital admission and mortality over the past 30 years, compli...

Jan 11th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

Feb 18th, 2016 - The Japanese Society of Gastroenterology (JSGE) revised the evidence-based clinical practice guidelines for peptic ulcer disease in 2014 and has created an English version. The revised guidelines consist of seven items: bleeding gastric and duoden...

May 12th, 2022 - Helicobacter pylori infection is a well-established risk factor for peptic ulcer disease and gastric cancer. It's now a consensus of experts that H.pylori infection should be treated once it is recognized. Extended proton pump inhibitor (PPI)-base...

Feb 16th, 2022 - Dyspepsia affects about 20% of the population globally and represents one of the commonest reasons for patients to seek medical consultation.1-3 The definition of dyspepsia has evolved over time and generally encompasses a variety of upper gastroi...

Feb 7th, 2022 - Retrospective chart review to be conducted at Methodist Richardson Medical Center (MRMC) in Richardson, TX. All adult patients hospitalized with COVID-19 on enoxaparin for DVT prophylaxis will be included. Collected data will be analyzed to determ...

Oct 19th, 2021 - Challenges in the treatment of Helicobacter pylori (H. pylori) include increasing antimicrobial resistance and patient's low tolerance to some regimens. Lactobacillus johnsonii (L. johnsonii) and Immunoglobulin Y (IgY) have been shown to decrease ...

Sep 23rd, 2021 - Helicobacter pylori is believed to affect more than half of the world's population and is thought to affect nearly 2 million people in Hong Kong alone1. It is a major cause of peptic ulcer disease and is implicated in the pathogenesis of the major...

Apr 11th, 2022 - Proton pump inhibitors (PPIs), when used for prior gastrointestinal bleeding (GIB), were associated with better survival for veterans with cirrhosis, a retrospective study found. Among more than 76,000 such patients, PPI use was associated with a ...

Jan 25th, 2022 - Helicobacter pylori is one of the most common chronic bacterial infections worldwide. Approximately half of the global population is believed to be infected with H pylori. It is a significant cause of peptic ulcer disease and gastric cancer, which...

Jan 23rd, 2022 - The safety and tolerability of TST001, a high affinity humanized IgG1 monoclonal antibody to CLDN18.2, is under investigation as a potential treatment option for patients with gastric/gastroesophageal junction (GEJ) cancer and other locally advanc...

Jan 20th, 2022 - Helicobacter pylori is a gram-negative microaerophilic bacterium that infects the lining of the stomach. It is the chief cause of chronic gastritis and the primary etiological agent for gastric cancer and peptic ulcer disease (PUD). Despite effort...

Nov 1st, 2021 - Akash Goel, MD While this month’s journal scan for clinical research reviews in exocrine pancreatic insufficiency (EPI) may not reveal a landmark paper, there certainly are novel findings worthy of note. In particular researchers Halabitska and Ba.